Research Topics
Genomes and Genes | S W LoweSummaryAffiliation: Cold Spring Harbor Laboratory Country: USA Publications
| Collaborators
|
Detail Information
Publications
Mouse genomic representational oligonucleotide microarray analysis: detection of copy number variations in normal and tumor specimensB Lakshmi
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA
Proc Natl Acad Sci U S A 103:11234-9. 2006....
Apoptosis in cancerS W Lowe
Cold Spring Harbor Laboratory, 1 Bungtown Road, PO Box 100, Cold Spring Harbor, New York, NY 11724, USA
Carcinogenesis 21:485-95. 2000..An intense research effort is uncovering the underlying mechanisms of apoptosis such that, in the next decade, one envisions that this information will produce new strategies to exploit apoptosis for therapeutic benefit...
Tumor suppression by Ink4a-Arf: progress and puzzlesScott W Lowe
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Curr Opin Genet Dev 13:77-83. 2003..Recent evidence emerging from mouse tumor models distinguishes the activities of p16(Ink4a) and p19(Arf) in regulating tumor onset and identifies differences in their responsiveness to drugs...
DNA damage responses and chemosensitivity in the E mu-myc mouse lymphoma modelC A Schmitt
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Cold Spring Harb Symp Quant Biol 65:499-510. 2000
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signalingA W Lin
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Genes Dev 12:3008-19. 1998..Consequently, constitutive MAPK signaling activates p53 and p16 as tumor suppressors...
Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biologyV Krizhanovsky
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Cold Spring Harb Symp Quant Biol 73:513-22. 2008..Understanding extracellular cues that regulate these processes may enable new therapies for these conditions...
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53C A Schmitt
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Genes Dev 13:2670-7. 1999..Consequently, INK4a/ARF and p53 mutations lead to aggressive tumors by disrupting overlapping tumor suppressor functions. These data have important implications for understanding the clinical behavior of human tumors...
Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivoC A Schmitt
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Blood Cells Mol Dis 27:206-16. 2001..This model, able to test any other candidate gene, will be particularly useful to study the implications of specific mutations for drug action in vivo...
Inactivation of the apoptosis effector Apaf-1 in malignant melanomaM S Soengas
Cold Spring Harbor Laboratory, New York 11724, USA
Nature 409:207-11. 2001..Apaf-1 loss may contribute to the low frequency of p53 mutations observed in this highly chemoresistant tumour type...
Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitorsL Zender
Cold Spring Harbor Laboratory, New York 11724, USA
Cold Spring Harb Symp Quant Biol 70:251-61. 2005..This model provides a powerful platform for applications like cancer gene discovery or high-throughput preclinical drug testing...
E1A signaling to p53 involves the p19(ARF) tumor suppressorE de Stanchina
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 USA
Genes Dev 12:2434-42. 1998..Synergistic effects between the p19(ARF) and DNA damage pathways in inducing p53 may contribute to E1A's ability to enhance radio- and chemosensitivity...
Oncogene-dependent apoptosis in extracts from drug-resistant cellsH O Fearnhead
Cold Spring Harbor Laboratory, New York 11724, USA
Genes Dev 11:1266-76. 1997..As this killing relies on an activity generated by an oncogene, the effect of these agents should be selective for transformed cells...
Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformationA W Lin
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA
Proc Natl Acad Sci U S A 98:5025-30. 2001..Thus, oncogenic ras can activate the ARF-p53 program to suppress epithelial cell transformation. Disruption of this program may be important during skin carcinogenesis and the development of other carcinomas...
The p53-Bcl-2 connectionM T Hemann
Cold Spring Harbor Laboratory, Howard Hughes Medical Institute, NY 11724, USA
Cell Death Differ 13:1256-9. 2006
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4aM Serrano
Cold Spring Harbor Laboratory, New York 11724, USA
Cell 88:593-602. 1997..Negation of ras-induced senescence may be relevant during multistep tumorigenesis...
Topoisomerase levels determine chemotherapy response in vitro and in vivoDarren J Burgess
Cold Spring Harbor Laboratory and Howard Hughes Medical Institute, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA
Proc Natl Acad Sci U S A 105:9053-8. 2008..These results highlight the utility of pooled shRNA screens for identifying genetic determinants of chemotherapy response and suggest strategies for improving the effectiveness of topoisomerase poisons in the clinic...
Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivoHans Guido Wendel
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA
Cancer Res 66:7639-46. 2006..Understanding these genotype-response relationships in human tumors will be important for the effective use of rapamycin or other compounds targeting the PI(3)K pathway in the clinic...
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancerEmily E Bosco
Department of Cell Biology, The Vontz Center for Molecular Studies, University of Cincinnati, College of Medicine, Cincinnati, Ohio 45267, USA
J Clin Invest 117:218-28. 2007..Thus, because the RB pathway is a critical determinant of tumorigenic proliferation and differential therapeutic response, it may represent a critical basis for directing therapy in the treatment of breast cancer...
Mad2 overexpression promotes aneuploidy and tumorigenesis in miceRocio Sotillo
Cancer Biology and Genetics Program, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Cell 11:9-23. 2007..These results demonstrate that transient Mad2 overexpression and chromosome instability can be an important stimulus in the initiation and progression of different cancer subtypes...
The gene encoding the splicing factor SF2/ASF is a proto-oncogeneRotem Karni
Cold Spring Harbor Laboratory, PO Box 100, Cold Spring Harbor, New York 11724, USA
Nat Struct Mol Biol 14:185-93. 2007..Knockdown of either SF2/ASF or isoform-2 of S6K1 is sufficient to reverse transformation caused by the overexpression of SF2/ASF in vitro and in vivo. Thus, SF2/ASF can act as an oncoprotein and is a potential target for cancer therapy...
Role of the chromobox protein CBX7 in lymphomagenesisClare L Scott
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA
Proc Natl Acad Sci U S A 104:5389-94. 2007..These data identify CBX7 as a chromobox protein causally linked to cancer development and may help explain the low frequency of INK4a/ARF mutations observed in human follicular lymphoma...
Tumorigenic activity and therapeutic inhibition of Rheb GTPaseKonstantinos J Mavrakis
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Genes Dev 22:2178-88. 2008..Of these, only eIF4E was able to enhance lymphomagenesis in vivo. In summary, the Rheb GTPase is an oncogenic activity upstream of mTORC1 and eIF4E and a direct therapeutic target of farnesyltransferase inhibitors in cancer...
mTORC1 promotes survival through translational control of Mcl-1John R Mills
Department of Biochemistry, McGill University, Montreal, QC, Canada H3G 1Y6
Proc Natl Acad Sci U S A 105:10853-8. 2008..Our results indicate that the extent by which rapamycin can modulate expression of Mcl-1 is an important feature of the rapamycin response...
Snapshot: genetic mouse models of cancerLars Zender
Cell 129:838. 2007
microRNAs join the p53 network--another piece in the tumour-suppression puzzleLin He
Watson School of Biological Sciences, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA
Nat Rev Cancer 7:819-22. 2007..These data reinforce the growing awareness that non-coding RNAs are key players in tumour development by placing miRNAs in a central role in a well-known tumour-suppressor network...
Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma modelMarie Eve Bordeleau
Department of Biochemistry, McGill University, Montreal, Quebec, Canada
J Clin Invest 118:2651-60. 2008..These results establish that targeting translation initiation can restore drug sensitivity in vivo and provide an approach to modulating chemosensitivity...
Probing tumor phenotypes using stable and regulated synthetic microRNA precursorsRoss A Dickins
Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Nat Genet 37:1289-95. 2005..In practice, this primary microRNA-based short hairpin RNA vector system is markedly similar to cDNA overexpression systems and is a powerful tool for studying gene function in cells and animals...
p400 is required for E1A to promote apoptosisAndrew V Samuelson
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA
J Biol Chem 280:21915-23. 2005..These results identify p400 as a regulator of the ARF-p53 pathway and a component of the cellular machinery that couples proliferation to cell death...
Apoptosis: a link between cancer genetics and chemotherapyRicky W Johnstone
Cancer Immunology Division, The Peter MacCallum Cancer Institute, Trescowthick Research Laboratories, Smorgon Family Building, St Andrews Place, East Melbourne, 3002 Victoria, Australia
Cell 108:153-64. 2002....
Apoptosis and chemoresistance in transgenic cancer modelsClemens A Schmitt
Max Delbruck Center for Molecular Medicine, Department of Hematology Oncology, Charité Campus and Virchow Hospital, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany
J Mol Med (Berl) 80:137-46. 2002....
Dissecting p53 tumor suppressor functions in vivoClemens A Schmitt
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA
Cancer Cell 1:289-98. 2002..Therefore, apoptosis is the only p53 function selected against during lymphoma development, whereas defective cell-cycle checkpoints and aneuploidy are mere byproducts of p53 loss...
Direct coupling of the cell cycle and cell death machinery by E2FZaher Nahle
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA
Nat Cell Biol 4:859-64. 2002..The data also underscore how cell cycle progression can be coupled to the apoptotic machinery...
Tumour suppression: something for nothing?Elisa de Stanchina
Nat Cell Biol 4:E275-6. 2002
An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivoMichael T Hemann
Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, New York 11724, USA
Nat Genet 33:396-400. 2003..In addition, intrinsic differences between individual shRNA expression vectors targeting the same gene can be used to create an 'epi-allelic series' for dissecting gene function in vivo...
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescenceMasashi Narita
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA
Cell 113:703-16. 2003..These results provide a molecular explanation for the stability of the senescent state, as well as new insights into the action of Rb as a tumor suppressor...
Control of apoptosis by p53Jordan S Fridman
Incyte Corporation, Wilmington, DE 19880, USA
Oncogene 22:9030-40. 2003..Understanding this network in more detail will provide insights into cancer and other diseases, and will identify strategies to improve their therapeutic treatment...
Executing cell senescenceMasashi Narita
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Cell Cycle 3:244-6. 2004..Here we show how these changes might contribute to the stability of the senescent state...
Reversing drug resistance in vivoHans-Guido Wendel
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Cell Cycle 3:847-9. 2004..They also illustrate the importance of tailoring cancer therapy based on tumor genotype...
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic controlEva Hernando
Department of Pathology, Memorial Sloan Kettering Cancer Center New York, New York 10021, USA
Nature 430:797-802. 2004....
Intrinsic tumour suppressionScott W Lowe
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA
Nature 432:307-15. 2004..Although oncogenic mutations that disable such networks can have profound and varied effects on tumour evolution, they may leave intact latent tumour-suppressive potential that can be harnessed therapeutically...
A conserved element in Myc that negatively regulates its proapoptotic activityAndreas Herbst
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA
EMBO Rep 6:177-83. 2005..These findings reveal a role for MbIII in Myc biology, and establish that the oncogenic capacity of Myc is linked directly to its ability to temper the apoptotic response...
The price of tumour suppression?Gerardo Ferbeyre
Nature 415:26-7. 2002
